| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/07/2009 | US20090117668 Immune Agglutination Reagent Kit and Method of Measuring Antigen |
| 05/07/2009 | US20090117590 Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof |
| 05/07/2009 | US20090117588 Methods of diagnosing pre-eclampsia or eclampsia |
| 05/07/2009 | US20090117587 for binding epitopes of Clostridium botulinum neurotoxin (BoNT) type A and hybridomas that produce such antibodies; kit for detecting BoNT/A |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117538 Methods for Obtaining Gene Tags |
| 05/07/2009 | US20090117135 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117128 Anti-HPA |
| 05/07/2009 | US20090117126 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
| 05/07/2009 | US20090117124 Anti-IgE antibodies |
| 05/07/2009 | US20090117122 Resistin Antagonists and Their Use |
| 05/07/2009 | US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427 |
| 05/07/2009 | US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 05/07/2009 | US20090117117 Targeting abcb5 for cancer therapy |
| 05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/07/2009 | US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/07/2009 | US20090117112 Immunomodulatory compositions and uses therefor |
| 05/07/2009 | US20090117110 Method for the In Vitro Assessment of the Progression Status of an Infection by an HIV Virus in an Individual |
| 05/07/2009 | US20090117109 Methods For Reducing Biofilm Formation In Infectious Bacteria |
| 05/07/2009 | US20090117108 Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody |
| 05/07/2009 | US20090117105 Humanized anti-venezuelan equine encephalitis virus recombinant antibody |
| 05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
| 05/07/2009 | US20090117101 HEH4 Molecules and Uses Thereof |
| 05/07/2009 | US20090117100 Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
| 05/07/2009 | US20090117097 Stabilizer for Protein Preparation Comprising Meglumine and Use Thereof |
| 05/07/2009 | US20090117096 Methods and compositions for inhibition of metastasis |
| 05/07/2009 | US20090117095 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 05/07/2009 | US20090117043 Antibodies That Specifically Bind to Neurokinin B |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117036 Antibodies against gpr64 and uses thereof |
| 05/07/2009 | US20090117032 Imaging Agents for Early Detection and Monitoring of Cardiovascular Plaque |
| 05/07/2009 | CA2805976A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2704527A1 Anti-hepcidin antibodies and uses thereof |
| 05/07/2009 | CA2704357A1 Improved nogo-a binding molecules and pharmaceutical use thereof |
| 05/07/2009 | CA2704315A1 Antibodies to gdf8 and uses thereof |
| 05/07/2009 | CA2704296A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | CA2704119A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 05/07/2009 | CA2704024A1 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals |
| 05/07/2009 | CA2703911A1 Molecules and methods for modulating complement component |
| 05/07/2009 | CA2703825A1 New antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs |
| 05/07/2009 | CA2703385A1 Fc variants with altered binding to fcrn |
| 05/07/2009 | CA2703279A1 Antibody purification by cation exchange chromatography |
| 05/07/2009 | CA2703263A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2702618A1 Radiolabeled monoclonal antibodies, methods of preparation using tcep, and uses thereof |
| 05/07/2009 | CA2700433A1 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6) |
| 05/06/2009 | EP2056112A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 05/06/2009 | EP2055786A2 Phosphospecific PAK antibodies and diagnostic kits |
| 05/06/2009 | EP2055777A2 Methods for producing members of specific binding pairs |
| 05/06/2009 | EP2055718A1 Targeting and tracing of antigens in living cells |
| 05/06/2009 | EP2055717A1 Prognostic method |
| 05/06/2009 | EP2055715A1 Anticomplement polypeptides of ixodes ricinus |
| 05/06/2009 | EP2055313A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2054518A2 Microbial synthesis of d-1,2,4-butanetriol |
| 05/06/2009 | EP2054444A2 Antibodies to erbb2 |
| 05/06/2009 | EP2054443A2 Antibodies to an epitope of agr2, assays and hybridomas |
| 05/06/2009 | EP2054442A2 Denatured collagen peptides and uses thereof |
| 05/06/2009 | EP2054431A2 Conformers of bacterial adhesins |
| 05/06/2009 | EP2054083A1 A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| 05/06/2009 | EP2054082A2 Therapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 05/06/2009 | EP2054061A2 Combination therapy |
| 05/06/2009 | EP2054044A1 Medicament for lct poisoning |
| 05/06/2009 | EP1963366A4 Methods for cyclic nucleotide determination |
| 05/06/2009 | EP1539785B1 Gene regulation in transgenic animals using a transposon-based vector |
| 05/06/2009 | EP1521967B1 Plasma urotensin in human heart failure |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1410022B1 Detection and treatment of prostate cancer |
| 05/06/2009 | EP1127142B1 Modulation of polypeptide display on modified filamentous phage |
| 05/06/2009 | CN101426936A Rabbit monoclonal antibodies to hepatitis b surface antigensand methods of using the same |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101426817A Antagonist anti-CD40 antibody pharmaceutical compositions |
| 05/06/2009 | CN101426816A Antibodies against human il-22 and uses therefor |
| 05/06/2009 | CN101426815A Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| 05/06/2009 | CN101426814A Compositions and methods for humanization and optimization of N-glycans in plants |
| 05/06/2009 | CN101426812A Methods for altering protein production rates |
| 05/06/2009 | CN101426528A Methods of using antibodies against human IL-22 |
| 05/06/2009 | CN101426527A Protein formulations |
| 05/06/2009 | CN101426526A Solution phase biopanning method using engineered decoy proteins |
| 05/06/2009 | CN101423811A Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101423552A Human-derived anti-human tissue factor Fab and preparation method thereof |
| 05/06/2009 | CN100485391C Use of daintain/inflammation factor 1 in preparing tag for diagnosing mammary cancer |
| 05/06/2009 | CN100485035C Novel scavenger albumen receptors |
| 05/06/2009 | CN100484956C Compound from catarrh mollase bacterial |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528240 Method for producing human anti-thymocyte immunoglobulins |
| 05/05/2009 | US7528239 Receptor that binds trail |
| 05/05/2009 | US7528238 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/05/2009 | US7528237 Binding to monoclonal antibodies; antitumor agents |
| 05/05/2009 | US7528236 Humanized anti-beta7 antagonists and uses therefor |
| 05/05/2009 | US7528235 antibodies that recognize chelating agents |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/05/2009 | US7527973 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein |
| 05/05/2009 | US7527972 Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation |
| 05/05/2009 | US7527969 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 05/05/2009 | US7527966 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 05/05/2009 | US7527949 Polysaccharides of Helicobacter pylori |
| 05/05/2009 | US7527939 Using immunoglobulins specific for brain natriuretic peptide to diagnose, classify, stratify and prognose mortality rates in patients with congestive heart failure; using biotin detector and peroxidase-labeled streptavidin reporter |